Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extended version with links to references, examples and case studies here
  • Read the article in Pharmaceutical Technology  here

 

Also in the Knowledge Center

Related Content

Explore what we do

Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

60 Years

In 2019, Hovione celebrates its 60th Anniversary.

Page
Read more

HPAPI – Highly Potent API

Our service for HPAPIs ranges from Drug Substance to Particle Engineering.

Page
Read more